Search

Your search keyword '"Ochiai, atsushi"' showing total 2,216 results

Search Constraints

Start Over You searched for: Author "Ochiai, atsushi" Remove constraint Author: "Ochiai, atsushi"
2,216 results on '"Ochiai, atsushi"'

Search Results

2. Baseline ctDNA gene alterations as a biomarker of survival after panitumumab and chemotherapy in metastatic colorectal cancer

3. Association between continuous cessation or reduction of drinking alcohol and improvement of multiple dysplastic lesions in patients with esophageal squamous cell carcinoma after endoscopic resection

9. Assessment of Elastic Laminal Invasion Contributes to an Objective pT3 Subclassification in Colon Cancer

10. Acquired gene alteration patterns and post-progression survival: PARADIGM study analysis.

11. Prospective analysis of the expression status of FGFR2 and HER2 in colorectal and gastric cancer populations: DS-Screen Study

13. Field Effect of Alcohol, Cigarette Smoking, and Their Cessation on the Development of Multiple Dysplastic Lesions and Squamous Cell Carcinoma: A Long-term Multicenter Cohort Study

14. Molecular subtypes of lung adenocarcinoma present distinct immune tumor microenvironments

15. Multicenter prospective in vivo study of an endocytoscope system (ECS) for superficial esophageal cancer

20. Machine-based counting of mitochondria in cells using immunohistochemical staining of formalin-fixed and paraffin-embedded sections

22. Figure S1 from Metabolic Hallmarks for Purine Nucleotide Biosynthesis in Small Cell Lung Carcinoma

23. Table S2 from Metabolic Hallmarks for Purine Nucleotide Biosynthesis in Small Cell Lung Carcinoma

24. Association between continuous cessation or reduction of drinking alcohol and improvement of multiple dysplastic lesions in patients with esophageal squamous cell carcinoma after endoscopic resection

25. PS4-4 Early tumor shrinkage and depth of response with first-line panitumumab or bevacizumab and mFOLFOX treatment in PARADIGM

29. Metabolic hallmarks for purine nucleotide biosynthesis in small-cell lung carcinoma

30. Fibroblast inhibition by tocilizumab enabled gemcitabine/nab‐paclitaxel rechallenge for pancreatic cancer

31. First-line (1L) panitumumab (PAN) vs bevacizumab (BEV) in patients (pts) with HER2 amplification (HER2amp+), RAS wild type (WT) metastatic colorectal cancer (mCRC) according to tumor sidedness.

41. FIGURE 5 from Tumor-infiltrating Leukocyte Profiling Defines Three Immune Subtypes of NSCLC with Distinct Signaling Pathways and Genetic Alterations

42. Table S3 from Tumor-infiltrating Leukocyte Profiling Defines Three Immune Subtypes of NSCLC with Distinct Signaling Pathways and Genetic Alterations

43. FIGURE 3 from Tumor-infiltrating Leukocyte Profiling Defines Three Immune Subtypes of NSCLC with Distinct Signaling Pathways and Genetic Alterations

44. Tumor-infiltrating leukocyte profiling defines three immune subtypes of NSCLC with distinct signaling pathways and genetic alterations

50. Alcohol Consumption and Multiple Dysplastic Lesions Increase Risk of Squamous Cell Carcinoma in the Esophagus, Head, and Neck

Catalog

Books, media, physical & digital resources